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Viruses such as Influenza and Ebola are enveloped in lipid bilayers annexed from host cells and 
containing glycoproteins essential for the infection process. At the molecular level little is known about 5 
the assembly process in terms of physical interactions between the lipids and glycoproteins.   In this paper 
we assemble HIV glycoproteins in lipid vesicles in order to examine envelope assembly, a process that is 
usually only executed under control of a host cell. Using atomic force microscopy it was possible to 
observe fusion of individual envelope like particles, and contrast this with the behaviour of lipid vesicles 
without envelope glycoproteins. It was found that the inclusion of glycoproteins caused the vesicles to 10 
distort and that the subsequent fusion "footprint" with a lipid bilayer was related to the envelopes’ unique 
morphology. This non- spherical morphology suggests that the presence of a viral capsid may be essential 
for the stability of an enveloped virus. Interactions between trans-membrane gp41 and gp120, the spikes 
protruding from a virion, were examined using supported lipid bilayers. Interactions between the gp120 
and membrane-located gp41 resulted in the assembly of unusual molecular wires, one molecule in height 15 
and with a zigzag arrangement of gp120 molecules. In this work we have shown that purely 
physical/chemical interactions have dramatic effects on glycoprotein/lipid assembly and should be 
considered in the development of virus based technologies such as virosomes.  
Introduction 
 Viruses including Ebola and HIV are enveloped in a lipid 20 
bilayer, forming a soft interface between a virus particle and its 
environment. Typically the viral envelope is composed of lipids 
from the cell membrane of its host, which it annexes when the 
virion buds from the cell membrane.1 In addition to the lipid 
components, the virus genome synthesises glycoproteins, which 25 
are inserted into the bilayer. These glycoproteins mediate the 
recognition and fusion between the virus and the host, allowing 
infection of a healthy cell with the viral genome. In the case of 
HIV, glycoproteins are derived from the polypeptide gp160, 
which is coded for by the env gene. This precursor then trimerizes 30 
in the endoplasmic reticulum, before being cleaved by furin 
proteases to form the gp120-gp41 complex. This complex is then 
transported to the cell surface via the Golgi, where the virion 
assembles.2–4 Both domains have well-established roles. The 
gp41 domain mediates the fusion between the virion and the 35 
target cell, whilst the gp120 domain protrudes from the lipid 
envelope and plays a crucial role in attachment to the CD4 
receptor on target cells.5,6 As such, the gp120 domain has long 
been seen as one of the most promising targets for a HIV vaccine, 
and indeed neutralizing antibodies have been shown to act by 40 
obstructing the interaction between gp120 and CD4 receptors.7
 These efforts however have been held back by obscurities in 
the conformational changes that take place during the receptor 
binding and fusion process. As a result the structure of the gp120-
gp41 heterodimer has only recently been reported.8 Extensive 45 
amounts of rapidly evolving N-linked glycosylation to the gp120-
gp41 complex also obscure the sites of interest. As the bond 
between gp41 and gp120 is non-covalent, it is relatively weak, 
thus when it is isolated the complex is unstable.9    
 As well as the relationship between lipids and glycoproteins, 50 
the composition of lipids in the envelope play an important part 
in envelope assembly and function. It has been hypothesised that 
organised gel-phase domains of phase-separated membranes play 
significant roles in cellular processes. If such membrane 
inhomogeneity is present in the viral envelope it could also affect 55 
the assembly process. The potential involvement of gel-phase 
domains in viral processes is consistent with the observation that 
virus budding from a host cell only occurs from specific 
compositions of the host cell membrane.10 In addition host cell 
lipid rafts have been shown to have a role in the budding process 60 
of the immature HIV virion, which have an analogous structural 
organization to the gel-phase domains.11  
 Atomic force microscopy (AFM) and single-molecule force 
spectroscopy have become useful tools for investigating the 
interactions of biomolecules with supported lipid bilayers (SLBs), 65 
simplified models of cell membranes. 12 These models possess 
the advantage of allowing physical phenomena such as self-
assembly and interactions to be dissociated from the biological. 
An added advantage of using AFM to examine model bilayer 
systems is that assembly processes can be followed with 70 
nanometre resolution under aqueous conditions. One such 
membrane system that incorporates complexity via phase 
separation of lipids is that of DOPC/DPPC, whereby the DPPC 
forms gel-phase islands in a liquid disordered DOPC phase. In 
this context HIV glycoprotein-lipid interactions have been probed 75 
with the ability to observe nanometre scale resolution in real time 
under physiologically relevant conditions. 13–15 
 In this work glycoprotein lipid interactions have been 
examined in order to better understand the assembly of the HIV 
envelope. Virion assembly is usually completed under direction 80 
of the host cell machinery, however an in vitro approach has the 
advantage of being able to elucidate the purely physical/chemical 
interactions of the biomolecular components. AFM was used to 
follow the fusion of gp160 reconstituted lipid vesicles, as mimics 
of the viral envelope, as they formed a supported lipid bilayer. 85 
Vesicles were extruded through 100nm pores to obtain uniform 
vesicles, 100nm in diameter, representative of the approximate 
120nm diameter of the HIV virion.16  
 Significant differences in both morphology and fusion 
 
behaviour were noted as a consequence of the presence of the 
gp160. In order to investigate the nature of the gp120-gp41 
complex, responsible for the "spikes" protruding from the HIV 
virion, gp41 was incorporated into phase-separated SLBs. Gp120 
was then adsorbed from solution onto this gp41-containing 5 
supported lipid bilayer. Molecular wires were formed when 
gp120 was adsorbed from solution onto the gp41 containing 
bilayer, further demonstrating the intricacies of lipid/glycoprotein 
interactions in the assembly process. 
 This observation has relevance for supramolecular chemistry, 10 
as exploiting this reversible host-guest interaction could be used 
to design nano-assemblies. A similar process has driven a strand 
of research focusing on cyclodextrin-based assemblies, a 
potential strategy applicable to the gp41-gp120 complex.17,18 
Virosomes are nanoparticles that contain inactive versions or 15 
fractions of a virus. They are used to elicit an immune response, 
generating antibodies against the viral antigen. Incorporating t 
host-guest interaction strategies into virosome development could 
lead to improved presentation of glycoproteins, giving a better 
chance of vaccine like effects.. This could be especially beneficial 20 
in the case of HIV as no effective vaccine exists. 
Materials and Methods 
HIV gp160 and gp41 reconstitution into vesicles 
 Incorporation of the HIV glycoproteins into vesicles and 
subsequent bilayer formation was achieved via reconstitution of 25 
the glycoproteins into lipid vesicles followed by extrusion 
resulting in unilamellar vesicles. Either HIV gp160 (ab73770, 
Abcam, UK) or gp41 (ab49070, Abcam, UK), depending on the 
experiment, were diluted in ultrapure water to a working 
concentration of 20µg mL-1. A 3:1 molar ratio of 1,2-dioleoyl-sn-30 
glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) (Avanti Polar Lipids) were 
dissolved in chloroform followed by drying under nitrogen. The 
dried lipid film was then re-suspended in ultrapure water to give a 
final concentration of 1mg mL-1. DOPC/DPPC vesicles were then 35 
subjected to 10 freeze-thaw cycles. The relevant glycoprotein 
(gp160 or gp41) was then added to the vesicle solution giving a 
protein concentration of 1µg mL-1. Following this the vesicles 
were extruded at 45°C ten times through a polycarbonate 
membrane (pore size 100nm) by means of a mini extruder 40 
(Avanti Polar Lipids).  
Supported lipid bilayer formation 
 Supported lipid bilayers were prepared via vesicle fusion. 
400µL of the liposome solution was pipetted onto freshly cleaved 
mica and allowed to anneal for 20 minutes at 45 °C. The surface 45 
was then gently washed 3 times with PBS to remove non-
absorbed vesicles prior to imaging. 19–21 
Gp120 Adsorption     
 For experiments where gp120 was adsorbed from solution onto 
a gp41-reconstituted bilayer, the gp120 (ab73769, Abcam, UK) 50 
solution was added to the preformed SLB and allowed to 
equilibrate for 60 minutes.  
Topographic AFM imaging 
 For images of vesicles interacting with the surface and forming 
a bilayer the standard annealing step was significantly shortened 55 
to 5 minutes. AFM measurements were performed in a liquid cell 
using an Agilent 5500 AFM microscope. Images were obtained in 
both contact and tapping mode. Contact mode images were 
obtained using nitrogen doped silicon tips with a nominal force 
constant of 0.02-0.77. Tapping mode images were obtained using 60 
silicon tips (Nanosensors series PPP-NCH) with a resonance 
frequency ~330 kHz and a force constant of 0.42 N m-1.  Forces 
were minimized during scans remaining below 1 nN, with typical 
scan rates in the range of 0.5–1 kHz at 512-pixel resolution. All 
measurements were performed in phosphate buffered saline 65 
(PBS) solution at ambient temperature (~20 °C). Image 
processing was performed using version 5.1.6 of the Scanning 
Probe Image Processor (SPIP) software (Image Metrology, 
Lyngby, Denmark). 
Force spectroscopy 70 
 Force spectroscopy experiments were conducted using 
backside aluminium coated silicon cantilevers (PPP-CONTR, 
Nanosensors, Switzerland) with a nominal spring constant of 0.02 
- 0.77 N m-1 and typical tip radius of less than 7 nm. Spring 
constants were calibrated using the equipartition theorem 75 
(Thermal K) as described by Hutter and Bechhoefer.22 At least 
1200 force-distance curves were obtained per sample with an 
applied load in the range of 9–10 nN, curve length of 1 µm and 
constant tip velocity of 1 µm s-1. Force spectra were analysed 
(using SPIP) to obtain unfolding forces. Only curves displaying 80 
well-defined sawtooth patterns that could be fitted to the 
wormlike chain model were attributed to single molecule pulling 
events.   
Results and Discussion 
 As a control the fusion behaviour of vesicles consisting of 85 
lipids only, i.e. without reconstituted gp160, was studied. 
Vesicles were composed of a binary mixture of DOPC and DPPC 
in a molar ratio of 3:1. Observation of fusing vesicles revealed 
the characteristic annular shape previously reported for vesicles 
collapsing on a surface (Fig. 1a). It is possible to resolve 90 
individual vesicles losing their individuality as they are 
incorporated into the lipid bilayer. The individual vesicles have a 
spherical morphology and a height of between 8 and 15nm. These 
structures have been investigated thoroughly by Jass et al. 23,24 
Eventually the fused vesicles form a complete bilayer (Fig. 1b), 95 
with island-like features corresponding to the gel phase domains. 
These are characteristic of phase separation and have a height 
between 1-2nm relative to the surrounding liquid disordered 
phase. 
  
Fig. 1. Atomic force microscopy images showing fusion of lipid vesicles 
to form a phase separated supported lipid bilayer. Bilayer imaged with a 
short annealing phase (5 minutes), allowing individual vesicles to be 
observed (a). Bilayer imaged with 20-minute annealing time, showing 5 
formation of a phase separated bilayer with typical gel phase islands 
(DPPC) surrounded by liquid disordered DOPC (b).  
 Vesicles reconstituted with gp160 were then deposited on a 
mica surface, and imaged quickly after formation in order to 
observe the intact envelope-like particles fusing with each other 10 
and the surface. The particles can be described as envelope-like 
as they are composed of a lipid bilayer with the HIV envelope 
glycoprotein reconstituted into this membrane, a simplified model 
of the HIV lipid envelope. For comparison lipid vesicles forming 
a bilayer are presented in Fig. 2a. Even at this resolution there is a 15 
striking difference in particle morphology between the HIV-
gp160 vesicles (Fig. 2b) and the control lipid only vesicles.  
 
Fig. 2. Comparison between plain lipid vesicles and envelope-like 
particles. DOPC/DPPC vesicles adsorbing onto the bilayer. These are 20 
round, uniform in size and of the correct dimensions to be single vesicles 
(a). Envelope-like particles, DOPC/DPPC vesicles reconsituted with 
gp160, adsorbing onto the bilayer. These are too large to be of single 
vesicle size and have a distinct morphology.  
It is clear that the gp160-laden vesicles form a larger, more 25 
disorganized structure in comparison to the small spherical 
vesicles containing only DOPC/DPPC. At higher resolution the 
distinct morphology (and size) of the envelope-like particles is 
obvious (Fig. 3b), in comparison to the individual lipid vesicles 
(Fig. 3a). 30 
There are two characteristic features in an individual HIV 
envelope-like particle (Fig. 3b), bright spots, with the brightness 
indicating height, and a less intense matrix. The bright spots are 
uniform in both height and size. The spots themselves are too 
small to be individual vesicles (vesicles having been extruded 35 
through 100nm pores), however they do appear to form a part of 
aggregated structures. Many of the aggregates show a 3-fold or 6-
fold assembly, which was previously reported for naked gp160 on 
mica.25 
 40 
Fig. 3. Comparison of the difference in features. Lipid only vesicles. 
These have a symmetrical doughtnut like structure on contact with the 
underlying bilayer, indicative of a sphere collapsing onto a surface (a) gp-
160 laden vesicles with no symmetry. The bright features are thought to 
be protruding gp160 molecules/clusters, within a lipid matrix (b) 45 
 These observations and the obvious differences between 
glycoprotein containing and control vesicles suggest that the 
incorporated glycoproteins distort the lipid vesicle shell, the 
protruding glycoproteins clearly visible. Given the size of the 
individual envelope like particles larger than the 100nm extrusion 50 
pore, it is possible that the glycoproteins have caused particle 
aggregation. This is not implausible as virus aggregation has been 
documented for HIV virus particles in vivo and has shown a 
relationship with infectivity.26 Confirmation of the protein nature 
of the bright features was obtained using force microscopy.  55 
 
Fig. 4, Force-separation profile of the bright features within an envelope-
like particle. A typical retraction curve shows multiple unfolding events 
indicative of the unfolding of a single protein molecule, in this case 
attributed to the unfolding of gp160 (a). A worm like chain fit to sawtooth 60 
features in the retraction curve (b).  
A typical force-separation profile of the bright features (Fig. 4a) 
shows multiple unfolding events characteristic of the unfolding of 
protein domains. Each of these unfolding events could be fitted to 
the worm like chain model (Fig. 4b), allowing the unfolding 65 
forces to be extracted. The form of the retraction curve and 
magnitude of the unfolding forces are characteristic of HIV–
 
gp160 measured previously. 25 This non-spherical morphology 
due to the inclusion of glycoproteins suggests that a protein 
capsid may be essential for the HIV virion to retain a spherical 
structure. Such an inference would be critical in the design of 
virosomes towards a HIV vaccine. Indeed virosomes 5 
incorporating gp41 have shown promise in recent years as an 
immunization strategy, thus their in vitro self-assembly properties 
when reconstituted into liposomes are of great interest.27 In 
addition, a major issue in the targeting of the gp41-gp120 
complex for vaccine design is the non-native forms of the Env 10 
gene that obfuscate the neutralization of the fusogenic form of 
Env. Unprocessed gp160, gp41 stumps and shed gp120 molecules 
have all been found to complicate the immune response. Hence 
an understanding of how the behaviour of these membrane 
proteins translates to a virosome system is an important factor in 15 
rationalizing their design.28–30 
Following the initial fusion of the gp160-laden vesicles with the 
supported lipid bilayer, the footprint of the fusion product could 
be seen to rearrange over time. From something resembling the 
initial envelope-like particle (Fig. 5a) to more ring-like structures 20 
(Fig. 5b), and finally domains that resemble the gel-phase in a 
phase separated bilayer. This is particularly interesting as it 
reveals how envelope-like particle morphology is preserved in the 
fusion process and rearranges over time. This can be a useful 
model for the fusion process of virion particles. 25 
 
Fig. 5. Following fusion with the bilayer, the gp160-loaded vesicles leave 
a characteristic footprint that differs considerably from the naked vesicle 
doughnut shape. Initial footprint (a). Rearrangement after 20 minutes (b). 
 Lipid bilayers incorporating only the transmembrane gp41 30 
section of the gp160 glycoprotein were then examined as a  
prelude to studying gp120-gp41 interactions. Topographic images 
present a similar landscape to the DOPC/DPPC only system with 
gel phase domains clearly defined. However, very small 
individual features can be observed in between the gel phase 35 
domains in the liquid disordered regions of the membrane (Fig 
6a). Given that such features are absent in the control 
DOPC/DPPC systems we assign these to be individual molecules 
or clusters of the transmembrane receptors gp41. In addition to 
these randomly distributed gp41 molecules, the height of the 40 
phase separated gel domains increase in some cases giving a 
mean feature height of 3.15nm, significantly higher than the 
approximate 1nm of the DPPC gel domain relative to the 
surrounding DPPC. This is consistent with previous studies 
having reported the size of the gp41 molecule as 8.8nm, causing 45 
the overall height of the bilayer to be 5-6nm.31,32 It is also 
possible to observe "streaky" gel phase domains (Fig. 6b) where 
only parts of the gel-phase domain contain gp41. Therefore it can 
be concluded that gp41 will partition into both the liquid 
disordered and the gel phase domains. 50 
 
 Fig. 6. Gp41 incorporated into a DOPC/DPPC bilayer. Gp41 can be 
observed randomly distributed in the liquid disordered phase (a). The 
transmembrane glycoprotein is also apparent in the gel phase domains, as 
characterised by non-uniform, height features on the gel-phase domains.  55 
 Gp120 was then adsorbed onto the bilayer surface in order to 
probe interactions with gp41 incorporated into the lipid bilayer. 
Immediately apparent from the AFM topography images were the 
presence of wire-like features, microns in length and nanometres 
in width (Fig. 7a, 7b). These wire features only form when gp41 60 
is incorporated in the bilayer, with gp120 exhibiting a random 
orientation in the absence of the trans-membrane glycoprotein. 
These wires only form in the presence of both gp120 and gp41, 
without the gp41 the glycoproteins adopt a random distribution.33 
On closer inspection, individual molecular features can be 65 
resolved (Fig. 8a) confirming the molecular nature of the wires. 
The deflection signal from the contact mode imaging, allows the 
extent of wire formation to be appreciated (Fig. 8b). 
 
Fig. 7. Gp120 adsorbed onto supported lipid bilayers containing gp41.  70 
Molecular wires microns in length have assembled and decorate the 
bilayer surface (a). Features are reproduced across the lipid bilayer with 
varying orientations (b). 
 
 
Fig. 8. Self-assembled molecular wires. Internal structure of wires 
cropped but not zoomed in from fig 7b (a). Deflection image of self-
assembled wires presenting extent of formation (b).  
The dimensions of the wires are consistent with single molecule 
heights, and multimer widths, fig. 9a and fig. 9b. These wires also 5 
assembled when a gold tip was functionalised with gp120 and 
scanned over the gp41 incorporating bilayer. Thus the most likely 
explanation for their assembly is that the non-covalent 
interactions responsible for holding the gp41-gp120 complex 
together compete with gp120 aggregation interactions causing 10 
directional assembly to occur.  In addition wires appear to exhibit 
a chirality, with one of two orientation, one a reflection of the 
other.  These preferred orientations are particularly clear in figure 
8b. Whether or not such structures can assemble in a biological 
context is debatable, however the wire formation does 15 
demonstrate the directional and competitive aspect of 
intermolecular forces and how these could play a role in virion 
assembly. 
 
Fig. 9. Dimensions of self-assembled moelcular wires. Height distribution 20 
(a). Width distribution (b).  
Conclusions 
HIV-gp160 reconstituted vesicles could be assembled and 
visualised to fuse with a supported lipid bilayer at single particle 
resolution. Although the gp160 protrusions were visible, the 25 
morphology was non-spherical unlike the actual HIV virion, 
suggesting that the protein capsid is necessary for virion stability. 
Interaction between two parts of the glycoprotein complex, the 
protruding gp120 and the transmembrane gp41 were shown to be 
relatively weak, although strong enough to allow self-assembly of 30 
molecular wires along a supported bilayer surface.  The forces 
driving the assembly are consistent with the non-covalent 
interactions thought to dictate the gp120-gp41 complex in vivo.34 
This work demonstrates that glycoprotein-lipid interactions are 
capable of driving and influencing assembly and thus should be 35 
considered in the development of virosome-based vaccines. 
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